What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary areas of study are Childhood Cancer Survivor Study, Cancer, Pediatrics, Internal medicine and Surgery.
Joseph P. Neglia has researched Childhood Cancer Survivor Study in several fields, including Odds ratio, Cohort study, Survival rate, Cumulative incidence and Sarcoma.
His study in Cancer is interdisciplinary in nature, drawing from both Disease, Age of onset, Single-nucleotide polymorphism, Radiation therapy and Cohort.
The various areas that Joseph P. Neglia examines in his Pediatrics study include Epidemiology, Incidence, Psychiatry, Epworth Sleepiness Scale and Cause of death.
His Internal medicine research integrates issues from Endocrinology and Oncology.
His Surgery research incorporates themes from Relative risk, Absolute risk reduction and Risk factor.
His most cited work include:
- Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study (634 citations)
- Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study (598 citations)
- Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. (564 citations)
What are the main themes of his work throughout his whole career to date?
Joseph P. Neglia mainly investigates Internal medicine, Pediatrics, Childhood Cancer Survivor Study, Cancer and Oncology.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Surgery.
Joseph P. Neglia combines subjects such as Absolute risk reduction and Sarcoma with his study of Surgery.
His Pediatrics study combines topics in areas such as Odds ratio, Epidemiology, Childhood cancer, Childhood Acute Lymphoblastic Leukemia and Risk factor.
His studies deal with areas such as Incidence, Cumulative incidence, Cohort study, Breast cancer and Cohort as well as Childhood Cancer Survivor Study.
His research investigates the connection between Cancer and topics such as Retrospective cohort study that intersect with problems in Survival rate.
He most often published in these fields:
- Internal medicine (44.53%)
- Pediatrics (39.25%)
- Childhood Cancer Survivor Study (33.96%)
What were the highlights of his more recent work (between 2013-2020)?
- Internal medicine (44.53%)
- Oncology (29.43%)
- Childhood Cancer Survivor Study (33.96%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Oncology, Childhood Cancer Survivor Study, Cancer and Pediatrics.
He focuses mostly in the field of Oncology, narrowing it down to topics relating to Thyroid and, in certain cases, Telomere.
His research integrates issues of Incidence, Cumulative incidence, Retrospective cohort study, Breast cancer and Cohort in his study of Childhood Cancer Survivor Study.
His biological study spans a wide range of topics, including Survival rate and Surgery.
The study incorporates disciplines such as Central nervous system and Gerontology in addition to Cancer.
Joseph P. Neglia interconnects Executive dysfunction, Hazard ratio, Confidence interval, Physical therapy and Headaches in the investigation of issues within Pediatrics.
Between 2013 and 2020, his most popular works were:
- Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. (271 citations)
- The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study (178 citations)
- Breast Cancer After Chest Radiation Therapy for Childhood Cancer (132 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Joseph P. Neglia spends much of his time researching Internal medicine, Childhood Cancer Survivor Study, Oncology, Cancer and Pediatrics.
The Childhood Cancer Survivor Study study combines topics in areas such as Incidence, Cumulative incidence, Standardized mortality ratio and Breast cancer, Epidemiology of cancer.
His Oncology research is multidisciplinary, relying on both Survival rate, Case-control study, Chemotherapy and Population study.
His Cancer research includes elements of Retrospective cohort study and Genetic predisposition.
His research in Pediatrics intersects with topics in Scoliosis, Intervention, Childhood cancer, Amputation and Cohort.
His Cohort study integrates concerns from other disciplines, such as Absolute risk reduction and Cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
